Loading clinical trials...
Loading clinical trials...
A Prospective Case Series of Subcutaneous Immunoglobulin for Prophylaxis of Infections in Patients With Chronic Lymphocytic Leukemia With Impaired Humoral Immunity
Conditions
Interventions
Hizentra
Locations
1
United States
Allergy, Immunology, Rheumatology at Rochester Regional Health
Rochester, New York, United States
Start Date
November 5, 2018
Primary Completion Date
July 3, 2020
Completion Date
July 3, 2020
Last Updated
August 26, 2020
Lead Sponsor
Rochester General Hospital
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions